Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats

被引:26
|
作者
Lai, KW
Cheng, LYL
Cheung, ALM
O, WS
机构
[1] Univ Hong Kong, Dept Anat, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Dept Biochem, Hong Kong, Hong Kong, Peoples R China
关键词
apoptosis; galactosemia; granulosa cells; inhibitor of apoptosis proteins; ovulation; rat (Sprague Dawley);
D O I
10.1007/s00441-002-0689-6
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Galactosemia is a genetic disease with deficiency of galactose-I-uridyltransferase, resulting in the accumulation of galactose or galactose-I-phosphate in the blood and tissues. Rats were fed with normal rat chow and with a high-galactose diet for 4 weeks to give control and galactosemic groups, and their ovarian function was studied. The two groups of rats were injected with pregnant mare's serum gonadotrophin (PMSG) and were killed at different time points after human chorionic gonadotrophin (hCG) injection. The number of oocytes ovulated in the controls was significantly higher than in the galactosemic group. Morphometric studies of the ovaries also showed a higher number of corpora lutea in the controls. Western blot analysis of granulosa cells showed that the overall expressions of Fas and FasL were lower in the control group and their expressions of inhibitor of apoptosis proteins (IAPs) were higher than in the galactosemic group, especially at 8 h post hCG injection. TDT-mediated dUTP-biotin nick end-labeling (TUNEL) and immunohistochemical staining of ovarian sections with Ki-67 and IAPs showed more apoptotic granulosa cells in the galactosemic group and the expressions of IAPs in granulosa cells also confirmed the result of the Western blot. These findings support our hypothesis that ovarian dysfunction in galactosemic rats is due to increased apoptosis in granulosa cells of maturing follicles.
引用
收藏
页码:417 / 425
页数:9
相关论文
共 50 条
  • [1] Inhibitor of apoptosis proteins and ovarian dysfunction in galactosemic rats
    K. W. Lai
    L. Y. L. Cheng
    A. L. M. Cheung
    W. S. O
    Cell and Tissue Research, 2003, 311 : 417 - 425
  • [2] Is x-linked inhibitor of apoptosis protein (Xiap) a determinant of ovarian failure in galactosemic rats?
    O, WS
    Wang, YF
    Tsang, BK
    BIOLOGY OF REPRODUCTION, 2000, 62 : 219 - 220
  • [3] Inhibitor of apoptosis proteins and apoptosis
    Wei, Yunbo
    Fan, Tingjun
    Yu, Miaomiao
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2008, 40 (04) : 278 - 288
  • [4] Inhibitor of apoptosis proteins
    不详
    NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (02) : 99 - 99
  • [5] POLYOL ACCUMULATION IN GALACTOSEMIC AND DIABETIC RATS - CONTROL BY AN ALDOSE REDUCTASE INHIBITOR
    DVORNIK, D
    SIMARDDU.N
    KRAMI, M
    SESTANJ, K
    GABBAY, KH
    KINOSHITA, JH
    VARMA, SD
    MEROLA, LO
    SCIENCE, 1973, 182 (4117) : 1146 - 1148
  • [6] Diosgenin, a Novel Aldose Reductase Inhibitor, Attenuates the Galactosemic Cataract in Rats
    Ji, Lixia
    Cheng, Lixia
    Yang, Zhihong
    JOURNAL OF DIABETES RESEARCH, 2017, 2017
  • [7] THE EFFECTS OF A NEW ALDOSE REDUCTASE INHIBITOR (TOLRESTAT) IN GALACTOSEMIC AND DIABETIC RATS
    SIMARDDUQUESNE, N
    GRESELIN, E
    DUBUC, J
    DVORNIK, D
    METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (10): : 885 - 892
  • [8] Investigating isoquinoline derivatives for inhibition of inhibitor of apoptosis proteins for ovarian cancer treatment
    Chen, Chen
    Wu, Jie
    Zhu, Pengfei
    Xu, Congjian
    Yao, Liangqing
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2017, 11 : 2697 - 2707
  • [9] Human ovarian cancer and cisplatin resistance: Possible role of inhibitor of apoptosis proteins
    Li, JL
    Feng, Q
    Kim, JM
    Schneiderman, D
    Liston, P
    Li, M
    Vanderhyden, B
    Faught, W
    Fung, MFK
    Senterman, M
    Korneluk, RG
    Tsang, BK
    ENDOCRINOLOGY, 2001, 142 (01) : 370 - 380
  • [10] PREVENTION OF CATARACT DEVELOPMENT IN SEVERELY GALACTOSEMIC RATS BY THE ALDOSE REDUCTASE INHIBITOR, TOLRESTAT
    SIMARDDUQUESNE, N
    GRESELIN, E
    GONZALEZ, R
    DVORNIK, D
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 178 (04): : 599 - 605